Repligen is a global life sciences company that develops and commercializes bioprocessing technologies to improve efficiency, speed, and flexibility in the manufacturing of biological drugs. The company serves biopharmaceutical companies, contract manufacturers, and life sciences organizations through four integrated product franchises: filtration systems for cell culture and fluid separation; chromatography columns and systems for purification; process analytics tools for monitoring bioprocessing; and protein-based reagents and growth factors. Repligen generates the majority of its revenue from consumable and single-use products, supported by growing hardware and equipment sales, with customers spread globally across North America, Europe, and Asia-Pacific, and products deployed across monoclonal antibodies, biosimilars, and emerging therapeutic modalities including cell and gene therapies.